Biosimilar and Compounded GLP-1 Growth: A Price-Lowering Force Biosimilars represent an intermediate pricing tier between brands and generics, with multiple semaglutide and tirzepatide biosimilars already approved or in development globally
Rim emphasized, In May last year, we announced a plan for spin-off to establish a pure holding company Samsung Epis Holdings by separating part of the investment division that was responsible for managing Samsung Bioepis, a subsidiary engaged in the biosimilar business, adding, Through this division, Samsung Biologics, which has been reborn as a pure CDMO company, has resolved structural complexity and potential conflicts of interest concerns, and after the division, has established a foundation for strengthening order competitiveness and enhancing corporate value and shareholder value by focusing on CDMO, its core business. Choi Mun-hee [email protected]
For instance, combining it with other carbonic anhydrase inhibitors (like zonisamide or acetazolamide) can increase the risk of kidney stone formation
- Mesotherapy/Intradermal
Nutrients 15 (24), 5096
-1775582746855.png&w=3840&q=75)
)
